New Treatment Options for Patients in First Relapse Oncology (08909091)Richardson, Paul
New Treatment Options for Cancer Patients, An Issue of Veterinary Clinics: Small Animal PracticeRuthanne Chun
Treatment options for hearing loss are mostly based on medical devices, including hearing aids and cochlear implants; there are no pharmacological therapeutics currently in widespread use. Hair cells in the inner ear are the sensory cells for the detection of sound; hair cells are frequently affected...
These leaflets are more than just informational brochures; they are tools that empower patients to take charge of their health. By providing clear, concise information, they enable patients to better understand their conditions and the available ...
11 suggest new treatment options in advanced breast cancer refractory to conventional chemotherapy. A double-blind crossover trial showed that anastrozole (ARI) should be given as first-line adjuvant therapy with tamoxifen (TAM) used after first progression for women with advanced breast cancer. ...
Official answer: Migraine Treatment The newest novel drug (approved March 9, 2023) for the treatment of migraine is Zavzpret...
Although much more needs to be understood about the various functions exerted by MLT and its mechanisms of action, three therapeutic agents (ramelteon, prolonged-release MLT, and agomelatine) are already in use, and MLT receptor agonists are now appearing as new promising treatment options for ...
This randomized, double-blind, placebo-controlled phase 2a study revealed that the treatment was safe and, at the highest dose tested, the virus burden and influenza symptoms were significantly lower than in the placebo treated group. In a follow up randomized, double-blind, placebo-controlled ...
It was usually difficult to get my patients into appropriate resources and due to my lack of tools and time to help these patients, I would often prescribe medications.
Drug resistance represents a significant obstacle in cancer treatment, underscoring the need for the discovery of novel therapeutic targets. Ubiquitin-specific proteases (USPs), a subclass of deubiquitinating enzymes, play a pivotal role in protein deubi